Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.
暂无分享，去创建一个
M. Ladanyi | A. Drilon | J. Berlin | S. Pfister | B. Geoerger | D. Hyman | O. Witt | D. Hong | S. Bielack | A. Pappo | S. Kummar | A. Dowlati | B. Childs | A. Farago | E. Rudzinski | R. Schilder | T. Laetsch | R. McDermott | F. Doz | J. Patel | M. Tahara | L. Mascarenhas | S. DuBois | N. Federman | Cornelis M. van Tilburg | C. V. van Tilburg | C. Albert | K. Rohrberg | R. Nagasubramanian | S. Nanda